Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Blue Owl OBDC Stock Outlook and Forecast Blue Owl posts 16 EPS miss with 7097 million revenue Twist TWST Stock Municipal Bond Tick Up 20260422 PRHIZ Presurance notches 198 percent EPS surprise for Q1 2024 stock price stays flat today MITQ Moving reports Q1 loss of 004 per share as stock slides 145 Honeywell Shares Outperform Market on Positive Developments Microsofts AI Adoption Reveals Costly Paradox Automation May Be More Expensive Than Human Labor Trump Signals Progress on Iran Nuclear Deal Strait of Hormuz Reopening in Focus Bessent Anticipates Substantial Disinflation as Warshs Potential Fed Leadership Looms Market Highs Consumer Lows Survey Reveals Spending Pullback as Wall Street Rallies Tesla Brings Full SelfDriving Supervised to China After Long Delays as Domestic Rivals Advance 111 Inc Q3 2024 Earnings Net Loss Widens Amid Market Pressures BGS Q1 2026 Earnings Earnings Beat Estimates by 457 as Bottom Line Exceeds Expectations FPH Q1 2026 Earnings Narrowing Loss Amid Challenging Market Conditions UTHR Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges NYC Q1 2026 Earnings Wide Loss Highlights Ongoing Challenges for American Strategic Investment Co NAMS Q1 2026 Earnings Narrowed Loss Per Share Surpasses Expectations Amid Continued Pipeline Development Cypherpunk Technologies CYPH Slides 8 Can Support at 101 Hold Fortrea Holdings FTRE Slides Slightly Hovering Near Key Support Level Western Union WU Slips 153 as Technical Pressure Mounts Key Support at 795 Hilltop Holdings HTH Holds Steady Near Midpoint of Recent Range Neuronetics STIM Holds at 122 as Stock Consolidates Near Key Support Macerich Q1 2026 Earnings EPS Misses Estimates by 26 as Mall REIT Struggles Aditxt Inc ADTX Q3 2025 Earnings Significant Loss Per Share and No Revenue Amid Sharp Stock Decline Green Dot Corporation Q1 2026 Earnings Strong EPS Beat Highlights Improving Profitability MRNA Q1 2026 Earnings NarrowerThanExpected Loss Despite Revenue Absence RITM Q1 2026 Earnings Modest EPS Beat Highlights Steady Portfolio Performance NVO Q1 2026 Earnings EPS Surges Past Estimates as Obesity Drug Sales Drive Margin Gains